MentionFox
Home › funding signals › Salus Scientific Corp.
Form D · on the record

Salus Scientific Corp. — Form D filing, October 2026

Salus Scientific Corp. filed a Form D with the Securities and Exchange Commission on 2026-10-22.

Salus Scientific Corp. filed a Form D notice of an exempt securities offering with the SEC on October 22, 2026. Its industry group is Other Health Care. It names Todd Flohr (Executive Officer, Director), Keith Rosmarin (Executive Officer), Jon Wallace (Executive Officer, Director) (SEC Form D, October 22, 2026).

5 more Other Health Care raises within 90 days of this one ↓

Sell to companies like Salus Scientific Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

Run the free check on Salus Scientific Corp. →

Salus Scientific Corp.

New Form D on file · 2026-10-22 · the record

$0
raise on the record
D
filing
0
investors in
SOUTH CAROLINA
based
Open the record →

What the record says

FilingForm D
Filed2026-10-22
Industry groupOther Health Care
Entity typeCorporation
Incorporated inSOUTH CAROLINA
Year formed2021
BasedCHARLESTON, SOUTH CAROLINA
CIK1952070
Accession0001085146-26-000912

Pitching, partnering or investing alongside them? See who really runs and owns Salus Scientific Corp.

Watch Salus Scientific Corp.

Free to see. No signup.

Keep reading

More on the people and the money behind Salus Scientific Corp., from the filings we hold.

More raises like this

Other Health Care raises filed within 90 days of this one, largest first.

What do you want to do with Salus Scientific Corp.?

Get the full cited report on Salus Scientific Corp.

What the filing shows about Salus Scientific Corp.

  • The filing reports $900K of the proceeds going to the company's own executives, directors or promoters.
  • The filing names 8 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Salus Scientific Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

What the filing says

  • Offered: $30,000,000. Sold: nothing yet. Left to sell: $30,000,000. (filing)
  • Investors: 0 had already invested. (filing)
  • Date of first sale: yet to occur. (filing)
  • Types of securities: Equity. (filing)
  • Item 16, payments to executive officers, directors or promoters: $900,000 of the proceeds is used or proposed to be used for such payments (the filing marks this amount as an estimate). The filing gives no explanation. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Salus Scientific Corp. See pricing

Filing history · 5 filings on this registrant
Form D · 2022-11-10 · $335KForm D · 2024-10-29Form D · 2026-02-09 · $139KForm D/A, amended · 2026-08-05 · $10.12MForm D · 2026-10-22 · this page 2022-11-10 2026-10-22

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Other Health Care · by week

Trailing twelve months. 868 filings in Other Health Care, totalled by week.

Want the whole picture on Salus Scientific Corp.?

What the filing shows about Salus Scientific Corp.

  • The filing reports $900K of the proceeds going to the company's own executives, directors or promoters.
  • The filing names 8 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Salus Scientific Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Salus Scientific Corp. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Salus Scientific Corp.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Salus Scientific Corp.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/salus-scientific-corp-form-d-000912
Last updated 2026-10-25
Primary record: SEC filing 1 · SEC filing 2
Salus Scientific Corp. — SEC Form D filing, October 2026. MentionFox, 2026-10-25. https://mentionfox.com/funding/salus-scientific-corp-form-d-000912